These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38361704)

  • 61. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
    Aletaha D; Nell VP; Stamm T; Uffmann M; Pflugbeil S; Machold K; Smolen JS
    Arthritis Res Ther; 2005; 7(4):R796-806. PubMed ID: 15987481
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical value of MDHAQ for disease activity assessment in patients with rheumatoid arthritis].
    Yang M; Wang Y; Xie QB; Cen XR; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):285-8. PubMed ID: 25924447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.
    Hirata S; Saito K; Kubo S; Fukuyo S; Mizuno Y; Iwata S; Nawata M; Sawamukai N; Nakano K; Yamaoka K; Tanaka Y
    Arthritis Res Ther; 2013 Sep; 15(5):R135. PubMed ID: 24286472
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between Rheumatoid Arthritis Disease Activity and Risk of Ovarian Malignancy in Middle-Aged and Elderly Women.
    Huang Z; Tan L; Ling Y; Huang F; Ma W
    Biomed Res Int; 2022; 2022():1062703. PubMed ID: 35663045
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry.
    Koh JH; Lee Y; Kim HA; Kim J; Shin K
    Ther Adv Musculoskelet Dis; 2022; 14():1759720X221096363. PubMed ID: 35586514
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria.
    Smolen JS; Aletaha D; Gruben D; Zwillich SH; Krishnaswami S; Mebus C
    Arthritis Rheumatol; 2017 Apr; 69(4):728-734. PubMed ID: 27907269
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations.
    Canhão H; Rodrigues AM; Gregório MJ; Dias SS; Melo Gomes JA; Santos MJ; Faustino A; Costa JA; Allaart C; Gvozdenović E; van der Heijde D; Machado P; Branco JC; Fonseca JE; Silva JA
    Front Med (Lausanne); 2018; 5():40. PubMed ID: 29662880
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints.
    Heegaard C; Dreyer L; Egsmose C; Madsen OR
    Clin Rheumatol; 2013 Oct; 32(10):1493-500. PubMed ID: 23754243
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
    Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
    Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.
    Pincus T; Bergman MJ; Yazici Y; Hines P; Raghupathi K; Maclean R
    Rheumatology (Oxford); 2008 Mar; 47(3):345-9. PubMed ID: 18238788
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinicodemographic Profiles of Rheumatoid Arthritis Patients from a Single Center in Saudi Arabia.
    Bawazir YM
    Open Access Rheumatol; 2020; 12():267-275. PubMed ID: 33262665
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of Disease Activity Score (DAS28) and Routine Assessment of Patient Index Data 3 (RAPID3) for Assessment of Rheumatoid Arthritis Disease Activity, in the Indian Setting.
    Shah A; Kini S; Londhey V
    J Assoc Physicians India; 2019 Jul; 67(7):58-60. PubMed ID: 31559770
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition.
    Schoels M; Alasti F; Smolen JS; Aletaha D
    Arthritis Res Ther; 2017 Jul; 19(1):155. PubMed ID: 28676129
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis.
    Radovits BJ; Fransen J; van Riel PL; Laan RF
    Ann Rheum Dis; 2008 Aug; 67(8):1127-31. PubMed ID: 17965425
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis.
    Futó G; Somogyi A; Szekanecz Z
    Clin Rheumatol; 2014 May; 33(5):623-9. PubMed ID: 24599677
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
    Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
    Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.
    Maynard C; Mikuls TR; Cannon GW; England BR; Conaghan PG; Østergaard M; Baker DG; Kerr G; George MD; Barton JL; Baker JF
    Arthritis Care Res (Hoboken); 2020 Mar; 72(3):326-333. PubMed ID: 30875461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correlation of the Multi-Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis.
    Johnson TM; Register KA; Schmidt CM; O'Dell JR; Mikuls TR; Michaud K; England BR
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1459-1472. PubMed ID: 30320973
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Subcutaneous abatacept in rheumatoid arthritis: A real-life experience.
    Sarmiento-Monroy JC; Parada-Arias L; Rodríguez-López M; Rodríguez-Jiménez M; Molano-González N; Rojas-Villarraga A; Mantilla RD
    J Transl Autoimmun; 2019 Dec; 2():100016. PubMed ID: 32743504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.